DDIs between corticosteroids and cobicistat or ritonavir

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1766卷 / 1期
关键词：
D O I：
10.1007/s40278-019-66078-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [31] Interaction of CYP3A4 with the inhibitor cobicistat: Structural and mechanistic insights and comparison with ritonavir
    Sevrioukova, Irina F.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 758
  • [32] Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir
    Bartels, Hanni
    Decosterd, Laurent
    Battegay, Manuel
    Marzolini, Catia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2574 - 2577
  • [33] Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
    Gutierrez-Valencia, Alicia
    Trujillo-Rodriguez, Maria
    Fernandez-Magdaleno, Tamara
    Espinosa, Nuria
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [34] Ritonavir- or cobicistat-boosted antiretroviral therapy and direct oral anticoagulants: A case for apixaban
    Nisly, Sarah A.
    Stevens, Brooke N.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (07) : 718 - 722
  • [35] EXTRAPOLATION OF DACLATASVIR DOSING RECOMMENDATIONS FROM RITONAVIR BOOSTED PROTEASE INHIBITORSTO COBICISTAT PROTEASE INHIBITORS
    Gandhi, Y.
    Wang, Q.
    Li, W.
    Eley, T.
    Zheng, M.
    LaCreta, F.
    Bertz, R.
    Garimella, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S65 - S65
  • [36] In Vitro Inhibition of Human UGT Isoforms by Anti-HIV Boosting Drugs, Ritonavir and Cobicistat
    Alam, Novera
    Algeelani, Sara
    Hossain, Amin
    Greenblatt, David
    FASEB JOURNAL, 2017, 31
  • [37] Corticosteroids/ritonavir interactionSecondary adrenal insufficiency: 23 case reports
    Reactions Weekly, 2019, 1752 (1) : 110 - 110
  • [38] Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
    Fisher, Martin
    McDonald, Cheryl
    Moyle, Graeme
    Martorell, Claudia
    Ramgopal, Moti
    Laplante, Francois
    Curley, Joanne
    Graham, Hiba
    Tran-Muchowski, Cecilia
    Liu, Yapei
    Rhee, Martin
    Szwarcberg, Javier
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 203 - 203
  • [39] In monotherapy, darunavir/cobicistat demonstrates equivalence to darunavir/ritonavir, and in selected patients is as effective as bitherapies or triple therapies
    Pasquau, Juan
    Garcia-Vallecillos, Coral
    Teresa Cruces-Moreno, Maria
    Elizabeth de Jesus, Samantha
    Fatoul del Pino, Georgette
    Hidalgo-Tenorio, Carmen
    Vinuesa-Garcia, David
    Angel Lopez-Ruz, Miguel
    Hernandez-Quero, Jose
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [40] Clinical outcomes of patients switched to darunavir/cobicistat from boosted ritonavir-based antiretroviral therapy
    Warren, S.
    Clark, F.
    Cousins, D.
    Attridge, S.
    HIV MEDICINE, 2017, 18 : 15 - 16
12345